Halofantrine hydrochloride (SKF-102886) is an orally active antimalarial drug that is effective against drug-resistant Plasmodium falciparum and Plasmodium vivax[1]. Halofantrine hydrochloride (SKF-102886) can block delayed rectified potassium current by inhibiting the human Ether-a-go-go-related gene (HERG) channel.
References:
[1] Bryson H M, Goa K L. Halofantrine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic potential[J]. Drugs, 1992, 43(2): 236-258.
Halofantrine hydrochloride (SKF-102886)是一种具口服活性的抗疟药,能够有效对抗耐药性恶性疟原虫和间日疟原虫[1]。Halofantrine hydrochloride (SKF-102886)能够通过抑制人Ether-a-go-go相关基因(HERG)通道来阻断延迟整流钾电流。
















